Branded Generics Market – Global Industry Analysis and Forecast (2023-2029) by Type, Application and Region


Branded Generics Market size was valued at US$ 23.54 Bn in 2022 and the total revenue is expected to grow at 5.2% through 2023 to 2029, reaching nearly US$ 33.57 Bn.

Branded Generics Market Overview:

Branded generics are the most updated version of an off-patent drug that is promoted by either a patented drug manufacturer or generic drug companies that build brand equity for their generic drug versions. The pharmaceutical sector is characterized by several internal and external dynamics linked to licensing, production, and marketing. The notion of patenting is extremely important in the pharmaceutical industry.

Branded Generics MarketTo know about the Research Methodology :- Request Free Sample Report

The report has covered the market trends from 2017 to forecast the market through 2026=9. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Branded Generics Market Dynamics:

A large increase in cardiometabolic risk factors among the general population is driving the global market. The rising incidence of cancer cases is also contributing to the growth of the Branded Generics Market. The misapplication of risk evaluation and mitigation techniques (REMS) to Branded Generics Market entrance, on the other hand, is expected to stymie market expansion over the forecast period.

As a substantial number of pharmaceutical products become off-patent throughout the forecast period, the worldwide branded generics market is expected to increase rapidly. Simple marketing approval procedures, new player participation, changing medication procedures, and higher profit margins are all expected to boost the worldwide branded generics industry. Large rivalry from branded pharmaceuticals and commodity generic products are some of the major hurdles.

In low- and middle-income nations, demand for branded generics is growing. They are significantly more widespread in nations such as India, China, Brazil, and Mexico, where there are few other options for middle- and lower-income consumers. More than 70% of the world's population lives in emerging markets. These markets can be challenging for pharmaceutical companies that are more accustomed to functioning in established markets. To break into new markets, branded generic companies use a variety of techniques. They're honing their contracting skills and honing their portfolio marketing strategies.

To achieve a competitive advantage in the branded generics industry, key players are focusing on supplying low-cost branded generics. As an example, Mylan, a worldwide pharmaceutical firm, announced the launch of its remdesivir under the brand name DESREM in India in 2020 to meet unmet requirements related to the COVID-19 pandemic. The medicine is licensed for the treatment of adults and children with severe illness symptoms who have a COVID-19 infection. In Additions, Teva pharmaceuticals is a US affiliate. Teva Pharmaceuticals, in the US., announced the launch of THIOLA (tiopronin) tablets in May 2021 for the treatment of cystine (kidney) stones. Hence, these factors are estimated to boost the market expansion

Branded Generics Market Segment Analysis:

The Oral segment is anticipated to adhere to the growth of the Branded Generics Market.

The oral route of administration a projected to dominate the growth of the market. Oral drugs are simple to administer, and patient compliance is higher than with alternative administration methods. Sweeteners and colorful coatings are also being used to make tablets and capsules more pleasant. Oral formulations are of various types such as tablets, capsules, emulsions, suspension, liquids, powder, decoction, and others. Also, oral medicines are easy to administer and are the most preferred route of administrations as compare to parenteral, vaginal, and others. Further, tablets and capsules offer accurate dosage and high drug stability. Though, the unpredictable nature of gastrointestinal absorption may hamper the growth of the market. Due to the continued rise in demand for novel oral medications, the market is likely to grow. The use of various technologies for oral drug administration is altering the market landscape – this sector has gotten a lot of attention from pharmaceutical corporations because of the benefits that research can give, such as reformulations, which can reposition medications and extend patent expiration.

The Retail Pharmacies segment is supplementing the growth of the Branded Generics Market.

Retail pharmacy accounted for the largest market share in 2019. The growing advancement in medical infrastructure and increasing penetrations of health insurance are highly impacting the growth of retail pharmacies. The increase in the geriatric population, health awareness among people are some of the factors likely to drive the growth of the market in the forecast period. Online pharmacy is likely to gain significant. Manufacturers are forming ties with online and retail pharmacies as e-commerce grows. COVID-19's unprecedented epidemic normalised branded generics purchasing through online pharmacies. Directly ordering medication from online pharmacies is convenient and time-saving for patients. As a result, online pharmacies are expected to grow in popularity through 2021 and beyond.

Branded Generics Market Regional Insights:

Asia Pacific is estimated to dominate the growth of the market with a CAGR of 3.8% in the forecast period. As china is leading in Asia Pacific. China's pharmaceutical sector is fuelled by the low cost and widespread use of branded generic medications. China's drug evaluation and approval system has been streamlined, allowing more new domestic drugs, innovative drugs, and foreign drugs to reach the market. In China, the market is fiercely competitive, with the government in charge of medicine approval and development. The market in the country is being driven by the rising popularity of generic and branded generics, which have cost-effective features. China will publish and update the list of generic pharmaceuticals at the end of each year, according to a work plan announced jointly by 12 government departments, including the National Health Commission.

The objective of the report is to present a comprehensive analysis of the Global Branded Generics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Branded Generics Market dynamics, structure by analyzing the market segments and project the Global Branded Generics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Branded Generics Market make the report investor’s guide.

Branded Generics Market Scope: Inquire before buying






Branded Generics Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 23.54 Bn.




Forecast Period 2023 to 2029 CAGR:
5.2%
Market Size in 2029:
US $ 33.57 Bn.




 Segments Covered:
by Formulation Types
• Oral
• Parenteral
• Topical
• Others




by Drug Class
• Alkylating Agents
• Antimetabolites
• Hormones
• Anti-Hypertensive
• Lipid Lowering Drugs
• Anti-Depressants
• Anti-Psychotics
• Anti-Epileptics




by Application
• Oncology
• Cardiovascular Diseases
• Diabetes
• Neurology
• Gastrointestinal Diseases
• Dermatology Diseases
• Analgesics and Anti-inflammatory
• Others




by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies






Branded Generics Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Branded Generics Market Key Players

• Teva
• Abbott Laboratories
• Novartis
• Mylan
• Pfizer
• Mylan N.V.
• Hospira Inc.
• Dr. Reddy’s Laboratories Ltd.
• Apotex Inc.
• GlaxoSmithKline Pharmaceuticals Limited
• Valeant
• ZydusCadila
• Sandoz
• Lupin Pharmaceuticals, Inc.
• Par Pharmaceutical Companies, Inc.
• Sanofi
• AstraZeneca

FAQs:

1. What is the global Branded Generics market value in 2020?
Ans: The global Branded Generics market value in 2022 was estimated as 23.54 Billion USD.

2. Which Formulation Type is likely to dominate the global Branded Generics market growth?
Ans: Oral formulation dominated the market in 2022. This high share is attributable to the high commercial viability of orally administered Therapeutic Applications and high preference for orally administered Branded Generics owing to ease in consumption.

3. Which Region is expected to dominate the global Branded Generics market during the forecast period?
Ans: Asia Pacific is dominating the global Branded Generics market in forecast period owing to rise in increasing productivity of generic drugs and cost-effectiveness.

4. What are the factors driving the Branded Generics market?
Ans: Key factors that are driving the Branded Generic market growth include Entry of new branded generics, encouraging use of branded generics by healthcare providers and professionals and two-tiered strategy are some of the key trends driving the market.

5. Who are the key players in the global Branded Generics market?
Ans: Top players included Pfizer Inc., Mylan N.V, Abbot Laboratories, Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Therapeutic Application
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Therapeutic Application
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Branded Generics Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Branded Generics Market
3.4. Geographical Snapshot of the Branded Generics Market, By Manufacturer share
4. Global Branded Generics Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porter Five Forces Analysis
4.1.6.1. The threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. The Threat of Substitute Formulation Types
4.1.6.5. The intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Branded Generics Market
5. Supply Side and Demand Side Indicators
6. Global Branded Generics Market Analysis and Forecast, 2022-2029
6.1. Global Branded Generics Market Size & Y-o-Y Growth Analysis.
7. Global Branded Generics Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
7.1.1. Oral
7.1.2. Parenteral
7.1.3. Topical
7.1.4. Others
7.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
7.2.1. Oncology
7.2.2. Cardiovascular Diseases
7.2.3. Diabetes
7.2.4. Neurology
7.2.5. Gastrointestinal Diseases
7.2.6. Dermatology Diseases
7.2.7. Analgesics and Anti-inflammatory
7.2.8. Others
7.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
7.3.1. Alkylating Agents
7.3.2. Antimetabolites
7.3.3. Hormones
7.3.4. Anti-Hypertensive
7.3.5. Lipid Lowering Drugs
7.3.6. Anti-Depressants
7.3.7. Anti-Psychotics
7.3.8. Anti-Epileptics
7.4. Others Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
8. Global Branded Generics Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Branded Generics Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
9.1.1. Oral
9.1.2. Parenteral
9.1.3. Topical
9.1.4. Others
9.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
9.2.1. Oncology
9.2.2. Cardiovascular Diseases
9.2.3. Diabetes
9.2.4. Neurology
9.2.5. Gastrointestinal Diseases
9.2.6. Dermatology Diseases
9.2.7. Analgesics and Anti-inflammatory
9.2.8. Others
9.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
9.3.1. Alkylating Agents
9.3.2. Antimetabolites
9.3.3. Hormones
9.3.4. Anti-Hypertensive
9.3.5. Lipid Lowering Drugs
9.3.6. Anti-Depressants
9.3.7. Anti-Psychotics
9.3.8. Anti-Epileptics
9.4. Others Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
10. North America Branded Generics Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Branded Generics Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
11.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
12. Canada Branded Generics Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
12.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
13. Mexico Branded Generics Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
13.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
14. Europe Branded Generics Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
14.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
15. Europe Branded Generics Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Branded Generics Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
16.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
17. France Branded Generics Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
17.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
18. Germany Branded Generics Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
18.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
19. Italy Branded Generics Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
19.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
20. Spain Branded Generics Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
20.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
21. Sweden Branded Generics Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
21.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
22. CIS Countries Branded Generics Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
22.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
23. Rest of Europe Branded Generics Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
23.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
24. Asia Pacific Branded Generics Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
24.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
25. Asia Pacific Branded Generics Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Branded Generics Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
26.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
27. India Branded Generics Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
27.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
28. Japan Branded Generics Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
28.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
29. South Korea Branded Generics Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
29.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
30. Australia Branded Generics Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
30.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
31. ASEAN Branded Generics Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
31.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
32. Rest of Asia Pacific Branded Generics Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
32.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
32.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
33. Middle East Africa Branded Generics Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
33.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
34. Middle East Africa Branded Generics Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Branded Generics Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
35.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
36. GCC Countries Branded Generics Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
36.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
37. Egypt Branded Generics Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
37.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
38. Nigeria Branded Generics Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
38.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
39. Rest of ME&A Branded Generics Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
39.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
40. South America Branded Generics Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
40.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
41. South America Branded Generics Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Branded Generics Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
42.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
43. Argentina Branded Generics Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
43.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
44. Rest of South America Branded Generics Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Formulation Types, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029
44.4. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Branded Generics Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Drug Classs and R&D Investment
45.2.2. New Formulation Types Launches and Formulation Types Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Distribution Channel Agreements
46. Company Profile: Key Players
46.1.1. Abbott Diabetes Care Inc
46.1.1.1. Company Overview
46.1.1.2. Financial Overview
46.1.1.3. Geographic Footprint
46.1.1.4. Grade Portfolio
46.1.1.5. Business Strategy
46.1.1.6. Recent Developments
46.1.2. Teva
46.1.3. Abbott Laboratories
46.1.4. Novartis
46.1.5. Mylan
46.1.6. Pfizer
46.1.7. Mylan N.V.
46.1.8. Hospira Inc.
46.1.9. Dr. Reddy’s Laboratories Ltd.
46.1.10. Apotex Inc.
46.1.11. GlaxoSmithKline Pharmaceuticals Limited
46.1.12. Valeant
46.1.13. ZydusCadila
46.1.14. Sandoz
46.1.15. Lupin Pharmaceuticals, Inc.
46.1.16. Par Pharmaceutical Companies, Inc.
46.1.17. Sanofi
46.1.18. AstraZeneca
47.Primary Key Insights
  • INQUIRE BEFORE BUYING